Abbott Labs's most recent trend suggests a bullish bias. One trading opportunity on Abbott Labs is a Bull Put Spread using a strike $37.00 short put and a strike $32.00 long put offers a potential 12.61% return on risk over the next 25 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $37.00 by expiration. The full premium credit of $0.56 would be kept by the premium seller. The risk of $4.44 would be incurred if the stock dropped below the $32.00 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Abbott Labs is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Abbott Labs is bullish.
The RSI indicator is at 72.67 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Abbott Labs
Wake up! Investors are way too complacent
Tue, 22 Oct 2013 17:13:00 GMT
CNNMoney.com – The opinions expressed in this commentary are solely those of Paul R. La Monica. Other than Time Warner, the parent of CNNMoney, Abbott Laboratories and AbbVie, La Monica does not own positions in any …
Must-know: Current medical devices risks and opportunities
Tue, 22 Oct 2013 15:57:58 GMT
Market Realist – The industry looks to be weathering the Obamacare storm, yet there are still a couple key reasons to be wary of the industry over the coming months.
Mead Johnson: Gaining Market Share In China, Citi Ups To Buy, $95 TP
Tue, 22 Oct 2013 15:34:00 GMT
Barrons.com – Mead Johnson (MJN), which generates 70% of its sales from emerging markets, is gaining market share in China, after its two foreign competitors – Danone and Abbott (ABT) – made substantial infant formula …
EU Parliament stops short of US-style approvals for medical devices
Tue, 22 Oct 2013 15:07:57 GMT
Reuters – The European Parliament backed plans on Tuesday to tighten EU rules on medical devices that stopped short of a U.S.-style pre-marketing approval system that industry had warned would delay the introduction …
DuPont Sees Revenue Boost Thanks To Latin America Agriculture Sales
Tue, 22 Oct 2013 15:03:00 GMT
Forbes – Kevlar and insecticides lift DuPont earnings per share to beat Street estimates
Also on Market Tamer…
Follow Us on Facebook